"Across all sectors, as many as eight companies are lined up for IPOs this week, according to IPO research firm Renaissance Capital. If all eight price their offerings this week, it would mark the most active week for IPOs since 2021, Renaissance said. Four on this list are biotech companies: Eikon Therapeutics, Veradermics, AgomAb Therapeutics, Spyglass Pharma. These biotechs could still go public even with the SEC closed. Before the government shut down, the agency late Friday filed a notice of effectiveness for each one."
"Government funding lapsed this past Saturday, sparking a partial government shutdown that has closed agencies not deemed essential for public safety and national security. The list of closed agencies includes the Securities and Exchange Commission, which must sign off on an IPO filing before a company can go public. The shutdown could be brief. House Speaker Mike Johnson said on Meet the Press that he expects the Senate-passed funding bill will go to a vote in the House of Representatives by Tuesday."
Government funding lapsed, producing a partial shutdown that closed nonessential agencies including the Securities and Exchange Commission. The SEC must normally process registration statements before IPOs can proceed, and the agency will not process new or pending filings until operations resume. House leadership expects a vote on a Senate-passed funding bill soon, which could reopen government services. As many as eight companies are lined up for IPOs this week, four of them in biotech, and the SEC filed notices of effectiveness for those biotechs before the shutdown. IPO activity in 2025 reached a four-year high, with 202 companies raising $44 billion, supported by stabilizing macroeconomic conditions.
Read at MedCity News
Unable to calculate read time
Collection
[
|
...
]